Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Partners Value Investments L.P. Announces 2024 Annual Results
-
Partners Value Investments Inc. Announces 2024 Annual Results
-
HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market
-
Safety Shot, Inc. Announces Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc. - Updated
-
Avista reaches all-party, all issues settlement in Oregon general rate case
-
Senvest Capital Reports Results for the Year Ended December 31, 2024
-
Summit State Bank Reports Revised Fourth Quarter 2024 Financial Results
-
Truss Faber Welcomes International Trade and Regulatory Attorney, Suzanne Garner
-
Knight Therapeutics Inc. ranks on The Globe and Mail’s sixth-annual Women Lead Here benchmark of executive gender diversity
-
Mulvihill Premium Yield Fund Announces Year End Results
-
Mulvihill Enhanced Split Preferred Share ETF Announces Year End Results
-
Rupert Resources Reports Audited Financial Results for the Ten Months Ending December 31, 2024
-
Premium Global Income Split Corp. Announces Year End Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results
-
Coherent Announces General Availability of Industry-First 100G ZR QSFP28-DCO With High Optical Output Power
-
Purpose Investments Inc. Announces 2025 First-Quarter Distributions for Purpose Specialty Lending Trust
-
Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update
-
Coherent Announces General Availability of Industry-First 100G ZR QSFP28-DCO With High Optical Output Power
-
GOGL – Changes to the Board composition
-
WF Holding Limited Announces Closing of Initial Public Offering
-
Token Cat Limited Announces Filing of its Annual Report on Form 20-F
-
Mandalay Resources Corporation Announces Filing of Annual Information Form and Updated NI 43-101 Technical Reports for its Björkdal and Costerfield Operations
-
RGC Resources, Inc. Declares Quarterly Dividend
-
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
-
Evome Medical Technologies Provides Market Update
-
Ninepoint Partners Announces Final March 2025 Cash Distribution for Ninepoint Cash Management Fund - ETF Series
-
Magna Posts 2024 Annual Report
-
Mawson Infrastructure Group Inc. Reports Fiscal Year 2024 Financial Results
-
Expo Experts, a TalentAlly Sub-Brand, Launches Clearance Match to Streamline Hiring of Cleared Talent
-
Osisko Files 2024 Year-End Disclosure Documents
-
PureTech Systems Integrates PurifAI with IMMIX’s Monitoring Platforms to Transform Video Alarm Validation
-
Brookfield Real Assets Income Fund Inc. Declares Q2 2025 Distribution Schedule
-
Markforged Announces Fourth Quarter and Full Year 2024 Results
-
United Community Banks, Inc. Announces Date for First Quarter 2025 Earnings Release and Conference Call
-
Traws Pharma Announces Management Updates
-
Lotus Technology to Report Unaudited Fourth Quarter and Full Year 2024 Financial Results on April 22, 2025
-
Nokia Corporation: Repurchase of own shares on 28.03.2025
-
Ambow Education Announces Second Half and Full-Year 2024 Financial Results
-
Destination Pet Resolves Ongoing Legal Dispute with Trupanion
-
Calibre Mining Announces Receipt of Interim Order and Filing and Mailing of Meeting Materials for Special Meeting of Securityholders in Connection With the Business Combination With Equinox Gold
-
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
-
Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups
-
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
-
Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups
-
FutureFuel Releases 2024 Results
-
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
-
Arbor Realty Trust Declares Preferred Stock Dividends
-
Pactiv Evergreen Inc. Announces Receipt of All Required Regulatory Approvals for Planned Acquisition by Novolex
-
EZCORP Announces Closing of Private Offering of $300,000,000 of Senior Notes Due 2032


